Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars: A physician survey in the United States and emerging markets.
Philip Edward Lammers
No relevant relationships to disclose
Carmen Criscitiello
No relevant relationships to disclose
Giuseppe Curigliano
No relevant relationships to disclose
Ira Allen Jacobs
Employment or Leadership Position - Pfizer